In this Channel Nine News interview, a clinician and patient talk of their experience with Parkinson’s and the PKG™
News & Events
Andrew Maxwell, CEO of Global Kinetics Corporation talks to Helen Dalley of Sky News Business about how the Parkinson’s KinetiGraph™
“Advanced Therapies” and “A walk through the stages” were the key topics at the 14th annual conference for the Parkinson’s Disease Nurse Specialist Association (PDNSA) Conference.
Based in the UK, the PDNSA acts as an international resource and network for specialist nurses and allied healthcare professionals working in the field of Parkinson’s disease management.
GKC were pleased to be able
Lead Parkinson’s research and support charity Parkinson’s UK will work with GKC to enable access to the Parkinson’s KinetiGraph™ (PKG™), for up to 200 people living with Parkinson’s throughout the UK.
The pilot will evaluate the benefits of the PKG™ as a measurement tool routinely used to support more effective clinical decision-making in the management of people with Parkinson’s.
GKC attended The 10th Swedish Movement Disorder Society meeting at Johannesburg Castle, Stockholm.
The program lead by key Swedish movement disorder specialists included discussions around “When oral medications fail” and “how to select therapy for fluctuations” in Parkinson’s disease.
Global Kinetics Corporation has achieved a key milestone, securing important US regulatory clearance to market their world leading Parkinson’s disease mobile health technology in the high value American market.